Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, open-label, parallel-group, 6 week treatment, multi-center, phase III study to investigate the efficacy and safety of 100 microg and 200 microg twice daily of budesonide turbuhaler and 50 microg and 100 microg twice daily of fluticasone Diskus in Japanese children with bronchial asthma aged 5-15

Next Previous
Trial Profile

A randomized, open-label, parallel-group, 6 week treatment, multi-center, phase III study to investigate the efficacy and safety of 100 microg and 200 microg twice daily of budesonide turbuhaler and 50 microg and 100 microg twice daily of fluticasone Diskus in Japanese children with bronchial asthma aged 5-15

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Budesonide (Primary) ; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca

    • Most Recent Events

    • 16 May 2010 Results were presented at the 106th International Conference of the American Thoracic Society.
    • 18 Dec 2007 Status change from in progress to completed.
    • 10 Aug 2007 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top